You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
|
|---|---|
| Published in |
Breast Cancer Research, March 2021
|
| DOI | 10.1186/s13058-021-01409-8 |
| Pubmed ID | |
| Authors |
Angela DeMichele, Massimo Cristofanilli, Adam Brufsky, Xianchen Liu, Jack Mardekian, Lynn McRoy, Rachel M. Layman, Birol Emir, Mylin A. Torres, Hope S. Rugo, Richard S. Finn |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 14% |
| Mexico | 1 | 5% |
| Argentina | 1 | 5% |
| France | 1 | 5% |
| Belgium | 1 | 5% |
| Japan | 1 | 5% |
| United Kingdom | 1 | 5% |
| United Arab Emirates | 1 | 5% |
| Unknown | 11 | 52% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 62% |
| Practitioners (doctors, other healthcare professionals) | 6 | 29% |
| Scientists | 2 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 91 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 16% |
| Other | 10 | 11% |
| Student > Doctoral Student | 5 | 5% |
| Student > Ph. D. Student | 4 | 4% |
| Student > Master | 4 | 4% |
| Other | 10 | 11% |
| Unknown | 43 | 47% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Nursing and Health Professions | 4 | 4% |
| Business, Management and Accounting | 1 | 1% |
| Other | 5 | 5% |
| Unknown | 50 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 167. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2021.
All research outputs
#246,639
of 25,728,855 outputs
Outputs from Breast Cancer Research
#21
of 2,066 outputs
Outputs of similar age
#7,465
of 455,862 outputs
Outputs of similar age from Breast Cancer Research
#1
of 31 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,066 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,862 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.